BXCL501 for Agitation in Schizophrenia
NCT03708315
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Schizoaffective Disorder
Interventions
DRUG:
Dexmedetomidine Hydrochloride
DRUG:
Placebos
Sponsor
Yale University